Skip to main content
Erschienen in: Current Diabetes Reports 12/2019

01.12.2019 | Health Care Delivery Systems and Implementation in Diabetes (ME McDonnell and AR Sadhu, Section Editors)

Academic Detailing in the New Era of Diabetes Medication Management

verfasst von: Jing Luo, Ellen Dancel, Sandeep Bains, Paul Fanikos, Michael A. Fischer

Erschienen in: Current Diabetes Reports | Ausgabe 12/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Educating clinicians on how to improve the medical management of type 2 diabetes in the modern pharmacologic era represents an enormous challenge given the number of medications available and the diversity across guideline recommendations. Academic detailing uses active social marketing techniques to deliver in-office, face-to-face educational encounters between a trained clinical educator (academic detailer) and a primary care clinician and can improve the quality of prescribing and management decisions, leading to better patient outcomes.

Recent Findings

This updated review provides context on how academic detailing programs can improve diabetes-related clinical knowledge and practice among primary care providers, incorporating the perspective of a field-based academic detailer. It also profiles 4 diabetes-specific academic detailing programs varying in geographic scope and detailing approach, based in Massachusetts, Pennsylvania, Vermont, and Saskatchewan Province (Canada).

Summary

Academic detailing can effectively overcome challenges to increasing the evidence-based use of newer glucose-lowering medications in primary care settings.
Literatur
1.
Zurück zum Zitat Soumerai SB, Avorn JL. Principles of educational outreach (‘academic detailing’) to improve clinical decision making. JAMA. 1990;263:549–56.CrossRef Soumerai SB, Avorn JL. Principles of educational outreach (‘academic detailing’) to improve clinical decision making. JAMA. 1990;263:549–56.CrossRef
2.
Zurück zum Zitat • Avorn J. Academic detailing:“marketing” the best evidence to clinicians. JAMA. 2017;317(4):361–2. This review describes the theoretical framework and evidence-base supporting academic detailing as one approach to improve the care of patients. CrossRef • Avorn J. Academic detailing:“marketing” the best evidence to clinicians. JAMA. 2017;317(4):361–2. This review describes the theoretical framework and evidence-base supporting academic detailing as one approach to improve the care of patients. CrossRef
3.
Zurück zum Zitat Majumdar SR, Guirguis LM, Toth EL, Lewanczuk RZ, Lee T, Johnson JA. Controlled trial of a multifaceted intervention for improving quality of care for rural patients with type 2 diabetes. Diabetes Care. 2003;26(11):3061–6.CrossRef Majumdar SR, Guirguis LM, Toth EL, Lewanczuk RZ, Lee T, Johnson JA. Controlled trial of a multifaceted intervention for improving quality of care for rural patients with type 2 diabetes. Diabetes Care. 2003;26(11):3061–6.CrossRef
4.
Zurück zum Zitat Trombetta DP, Heller DA. Can academic detailing move the needle for patients with diabetes in a state-based prescription drug benefit program? American Health & Drug Benefits. 2019;12(2):94. Trombetta DP, Heller DA. Can academic detailing move the needle for patients with diabetes in a state-based prescription drug benefit program? American Health & Drug Benefits. 2019;12(2):94.
5.
Zurück zum Zitat Awad MH, Ulbrich TR, Furdich KM, Schneider SR, Gothard DM. The effect of pharmacy-led, small-group academic detailing on prescribing patterns in an ambulatory care clinic. J Pharm Technol. 2019;35(2):56–63.CrossRef Awad MH, Ulbrich TR, Furdich KM, Schneider SR, Gothard DM. The effect of pharmacy-led, small-group academic detailing on prescribing patterns in an ambulatory care clinic. J Pharm Technol. 2019;35(2):56–63.CrossRef
6.
Zurück zum Zitat •• Fischer MA. Academic detailing in diabetes: using outreach education to improve the quality of care. Curr Diab Rep. 2016;16(10):98. This review describes academic detailing as an educational approach to improve diabetes care. CrossRef •• Fischer MA. Academic detailing in diabetes: using outreach education to improve the quality of care. Curr Diab Rep. 2016;16(10):98. This review describes academic detailing as an educational approach to improve diabetes care. CrossRef
7.
Zurück zum Zitat Cefalu WT, Kaul S, Gerstein HC, et al. Cardiovascular outcomes trials in type 2 diabetes: where do we go from here? Reflections from a diabetes care editors’ expert forum. Diabetes Care. 2018;41(1):14–31.CrossRef Cefalu WT, Kaul S, Gerstein HC, et al. Cardiovascular outcomes trials in type 2 diabetes: where do we go from here? Reflections from a diabetes care editors’ expert forum. Diabetes Care. 2018;41(1):14–31.CrossRef
8.
Zurück zum Zitat Davies MJ, D’Alessio DA, Fradkin J, et al. Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2018;61(12):2461–98.CrossRef Davies MJ, D’Alessio DA, Fradkin J, et al. Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2018;61(12):2461–98.CrossRef
9.
Zurück zum Zitat Inzucchi S. Clinical diabetes. Philadelphia: Saunders; 2006. Inzucchi S. Clinical diabetes. Philadelphia: Saunders; 2006.
11.
Zurück zum Zitat Gerstein HC, Colhoun HM, Dagenais GR, et al. Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial. American Diabetes Association. 2019;394(10193):131–8. Gerstein HC, Colhoun HM, Dagenais GR, et al. Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial. American Diabetes Association. 2019;394(10193):131–8.
12.
Zurück zum Zitat Care ADAJD. 9. Pharmacologic approaches to glycemic treatment: Standards of Medical Care in Diabetes—2019. Diabetes Care. 2019;42(Supplement 1):S90–S102.CrossRef Care ADAJD. 9. Pharmacologic approaches to glycemic treatment: Standards of Medical Care in Diabetes—2019. Diabetes Care. 2019;42(Supplement 1):S90–S102.CrossRef
13.
Zurück zum Zitat Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71(19):e127–248. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71(19):e127–248.
14.
Zurück zum Zitat Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the american college of cardiology/american heart association task force on clinical practice guidelines. Journal of the American College of Cardiology. 2019;139(25):e1082–143. Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the american college of cardiology/american heart association task force on clinical practice guidelines. Journal of the American College of Cardiology. 2019;139(25):e1082–143.
Metadaten
Titel
Academic Detailing in the New Era of Diabetes Medication Management
verfasst von
Jing Luo
Ellen Dancel
Sandeep Bains
Paul Fanikos
Michael A. Fischer
Publikationsdatum
01.12.2019
Verlag
Springer US
Erschienen in
Current Diabetes Reports / Ausgabe 12/2019
Print ISSN: 1534-4827
Elektronische ISSN: 1539-0829
DOI
https://doi.org/10.1007/s11892-019-1252-0

Weitere Artikel der Ausgabe 12/2019

Current Diabetes Reports 12/2019 Zur Ausgabe

Therapies and New Technologies in the Treatment of Diabetes (M Pietropaolo, Section Editor)

The Use of Non-insulin Agents in Gestational Diabetes: Clinical Considerations in Tailoring Therapy

Other Forms of Diabetes and Its Complications (JJ Nolan and H Thabit, Section Editors)

Diabetic Gastroparesis and Glycaemic Control

Lifestyle Management to Reduce Diabetes/Cardiovascular Risk (B Conway and H Keenan, Section Editors)

Natural Alternative Sweeteners and Diabetes Management

Lifestyle Management to Reduce Diabetes/Cardiovascular Risk (B Conway and H Keenan, Section Editors)

Glucose Management and the Sex Difference in Excess Cardiovascular Disease Risk in Long-Duration Type 1 Diabetes

Health Care Delivery Systems and Implementation in Diabetes (ME McDonnell and AR Sadhu, Section Editors)

Bridging the Gap for Patients with Diabetes and Cardiovascular Disease Through Cardiometabolic Collaboration

Microvascular Complications—Nephropathy (M Afkarian and B Roshanravan, Section Editors)

Crosstalk Between Lipids and Mitochondria in Diabetic Kidney Disease

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.